The9 Limited (NASDAQ:NCTY – Get Free Report) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 35,800 shares, a growth of 28.3% from the November 15th total of 27,900 shares. Based on an average daily trading volume, of 123,400 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.4% of the company’s stock are short sold.
Institutional Investors Weigh In On The9
An institutional investor recently raised its position in The9 stock. Independent Advisor Alliance lifted its stake in shares of The9 Limited (NASDAQ:NCTY – Free Report) by 17.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 16,232 shares of the technology company’s stock after buying an additional 2,422 shares during the quarter. Independent Advisor Alliance owned about 0.18% of The9 worth $110,000 as of its most recent SEC filing. Institutional investors and hedge funds own 0.54% of the company’s stock.
The9 Stock Performance
Shares of NCTY traded up $0.07 during mid-day trading on Friday, reaching $17.48. The company’s stock had a trading volume of 74,245 shares, compared to its average volume of 64,925. The9 has a 1-year low of $4.03 and a 1-year high of $20.59. The business has a 50-day simple moving average of $10.94 and a two-hundred day simple moving average of $8.70.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on NCTY
The9 Company Profile
The9 Limited operates as a cryptocurrency mining business in China, Eastern Europe, Asia, and North America. The company was formerly known as GameNow.net Limited and changed its name to The9 Limited in February 2004. The9 Limited was incorporated in 1999 and is headquartered in Shanghai, the People’s Republic of China.
Featured Stories
- Five stocks we like better than The9
- 5 Top Rated Dividend Stocks to Consider
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the Nasdaq? Complete Overview with History
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for The9 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The9 and related companies with MarketBeat.com's FREE daily email newsletter.